ARCHIVES

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

This article is from The Cancer Letter archive.

Vol. 03 No. 10 | March 11, 1977

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

June 11, 2004

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

December 13, 1996

DCBDC Bard Approves Expansion Of SPORE Program To GY Cancers; Okays Two other RFAs

December 4, 1992

Funding opportunities listed.

April 23, 2004

In Brief: NCI Grants Up Fourfold Since 1970; Rappaport, Jensen Speakers At Annual AACR,ASCO Meeting

April 25, 1975

Afinitor Suspension Approved For Rare Pediatric Brain Tumor

August 31, 2012